Syon Capital’s Globus Medical GMED Stock Holding History

Syon Capital’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$638K	Buy	7,408 +2,432	+49%	+$218K	0.03%	468
2025 Q4	$434K	Buy	4,976 +420	+9%	+$31.9K	0.02%	616
2025 Q3	$261K	Buy	+4,556	New	+$262K	0.01%	701

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Syon Capital's GMED Position: Q1 2026 in Review

Syon Capital increased its Globus Medical (GMED) stake by 49% in Q1 2026, buying an estimated $218K and bringing the position to 7,408 shares worth $638K. The position accounts for 0.03% of the portfolio, ranked #468.

Syon Capital first reported a position in GMED in Q3 2025 and has held it in 3 quarters since. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

Syon Capital held 7,408 shares of Globus Medical worth $638K as of Q1 2026.
Syon Capital bought 2,432 Globus Medical shares in Q1 2026, an estimated $218K.
Globus Medical made up 0.03% of Syon Capital's portfolio in Q1 2026, its #468 holding.
Syon Capital first reported a position in Globus Medical in Q3 2025 and has held it in 3 quarters since.
602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.